EUVIMEDEUVIMED entdecken
Vergleichsstudie

Incidence of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin vs. Compounded Rectal Diclofenac Prophylaxis

Laurens P Janssens, Aishwarya Yamparala, John Martin, John O'Meara, William S Harmsen, Thanmay Sathi, Elizabeth Lemke, Barham K Abu Dayyeh, Aliana Bofill-Garcia, Bret T Petersen, Andrew C Storm, Mark Topazian und 3 weitere

Digestive Diseases and Sciences · 2024

DOI: 10.1007/s10620-024-08604-5 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Digestive Diseases and Sciences, 2024. Verfasst von Laurens P Janssens und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Hauptthemen laut MEDLINE: Indomethacin, Diclofenac, Cholangiopancreatography, Endoscopic Retrograde, Pancreatitis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndomethacinDiclofenacCholangiopancreatography, Endoscopic RetrogradePancreatitisAdministration, RectalAnti-Inflammatory Agents, Non-SteroidalHumansFemaleMaleMiddle AgedRetrospective StudiesIncidenceAgedAdultRisk FactorsDrug Compounding

Stichwörter der Autor:innen

DiclofenacERCPEndoscopic retrograde cholangiopancreatographyIndomethacinPost-ERCP pancreatitis

Substanzen

IndomethacinDiclofenacAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Department of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
  • Department of Pharmacy, Mayo Clinic, Rochester, MN, USA.
  • Department of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, USA.
  • Department of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. law.ryan@mayo.edu.

Zitieren

APA

Janssens, L. P., Yamparala, A., Martin, J., O'Meara, J., Harmsen, W. S., Sathi, T., Lemke, E., Abu Dayyeh, B. K., Bofill-Garcia, A., Petersen, B. T., Storm, A. C., Topazian, M., Vargas, E. J., Chandrasekhara, V., & Law, R. J. (2024). Incidence of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin vs. Compounded Rectal Diclofenac Prophylaxis. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08604-5

Vancouver

Janssens LP, Yamparala A, Martin J, O'Meara J, Harmsen WS, Sathi T, et al. Incidence of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin vs. Compounded Rectal Diclofenac Prophylaxis. Digestive Diseases and Sciences. 2024. doi:10.1007/s10620-024-08604-5

BibTeX
@article{Janssens2024,
  author = {Janssens, Laurens P and Yamparala, Aishwarya and Martin, John and O'Meara, John and Harmsen, William S and Sathi, Thanmay and Lemke, Elizabeth and Abu Dayyeh, Barham K and Bofill-Garcia, Aliana and Petersen, Bret T and Storm, Andrew C and Topazian, Mark and Vargas, Eric J and Chandrasekhara, Vinay and Law, Ryan J},
  title = {Incidence of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin vs. Compounded Rectal Diclofenac Prophylaxis},
  journal = {Digestive Diseases and Sciences},
  year = {2024},
  doi = {10.1007/s10620-024-08604-5}
}
Kostenlos starten →